Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal stromal cells for therapy-resistant pediatric juvenile idiopathic arthritis
NL-OMON21350Recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Aug 2014
- Modality
- Mesenchymal Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of Provacel in juvenile idiopathic arthritis (JIA), sponsored by University Medical Center Utrecht. Primary endpoints: Safety: adverse events before and after MSC infusion and ACR Pedi 70 response. Started Aug 2014; status: recruiting.
02
Drugs
Provacel
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on NL-OMON21350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21350.